Internal Medicine Doctors in Andalusia, AL Accepting Medicare

6 Internal Medicine doctors found. Showing 1 - 6

Dr. Darshana Vyas, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 Medical Park Dr, Andalusia, AL 36420 Phone: 334-222-6041

Yongkuma C Yongkuma, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1212 E Three Notch St, Andalusia, AL 36420 Phone: 334-222-6041    Fax: 334-222-1595

Dr. Robert Irving Garver Jr., MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 822 South Three Notch St, Suite B, Andalusia, AL 36420 Phone: 888-681-5864    Fax: 334-222-6633

Dr. Vijay Vyas, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 125 Medical Park Dr, Andalusia, AL 36420 Phone: 334-222-6041

Gregory D Price Sr., MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 215 Medical Park Dr Ste 1, Andalusia, AL 36420 Phone: 334-222-4327    Fax: 334-222-4333

Dr. Rex Allen Butler, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 843 S Three Notch St, Andalusia, AL 36420 Phone: 334-222-8525    Fax: 334-222-3566

News Archive

Actavis receives final FDA approval for Zolpidem ER Tablets

Actavis, an international generic pharmaceuticals company, today announced that it has received final approval from the US Food & Drug Administration to market Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV. Distribution of the product has commenced.

Arcion reports top-line results from ARC-4558 Phase 2b clinical trial for painful diabetic neuropathy

Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced top-line results from a successful Phase 2b double-blind, randomized, placebo-controlled clinical trial of its lead topical pain candidate, ARC-4558, in adult patients with painful diabetic neuropathy (PDN). Arcion recently held an End of Phase 2 meeting with the United States Food and Drug Administration (FDA) and the ARC-4558 program is now poised to enter Phase 3 studies.

MicroJet injector for painless injections

Parents know all too well the pain experienced by their children - and themselves - when the time comes for immunizations at the doctor's office.

UTMB scientists to look at possible impact of Gulf oil spill on seafood safety

In an effort to determine the vulnerability of affected Gulf Coast communities following last year's BP oil spill,the National Institute of Environmental Health Sciences has awarded a five-year $7.85 million grant to a consortium of university researchers and Gulf Coast community groups led by the University of Texas Medical Branch at Galveston to examine the safety of Gulf seafood and the long-term health of those who consume it.

Read more Medical News

› Verified 7 days ago